Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

NCT01194440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Ductal Carcinoma in Situ
Estrogen Receptor-positive Breast Cancer
Progesterone Receptor-positive Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

DRUG: letrozole
DRUG: zoledronic acid

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins